| 1. | Merck Frosst Canada - Major Accomplishments Overview |
| | With the development of ® (montelukast sodium), the Merck Frosst Centre for Therapeutic Research has earned its place as one of the world's leading research centres.... |
| |
| 2. | Merck Frosst Canada - SINGULAIR® |
| | SINGULAIR® (montelukast sodium) is a significant innovation in the treatment of asthma.... Both approaches yielded good results over the next 10 years ; however, by 1991 it was clear that montelukast sodium (later to become SINGULAIR®) was the superior drug and the inhibition approach was finally dropped.... |
| |
| 3. | Merck Frosst Canada - Partners |
| | This line of research has led to the development of SINGULAIR® (montelukast sodium), an oral asthma medication that adults and children as young as age two can take daily to control their asthma symptoms.... |
| |
| 4. | Merck Frosst Canada - Our History |
| | Scientists at the Merck Frosst Centre for Therapeutic Research have been investigating leukotrienes since 1979. This line of research led to the development of SINGULAIR® (montelukast sodium) an oral asthma medication that adults and children as young as two can take daily to control their asthma symptoms.... |
| |
| 5. | Merck Frosst Canada - Welcome to the Scientist's Section |
| | Efforts in the leukotriene programs have yielded one highly effective and innovative medicine : the leukotriene D4 receptor antagonist SINGULAIR® (montelukast sodium) for bronchial asthma in adults and children as young as six.... |
| |
| 6. | Merck Frosst Canada - SINGULAIR® |
| | Merck Frosst Canada - SINGULAIR®PrSINGULAIR® (montelukast sodium tablets) (montelukast sodium chewable tablets) (montelukast sodium granules for oral use)Original Notice of Compliance (NoC). |
| |
| 7. | Asthma - Adults |
| | PrSINGULAIR ® (montelukast sodium) is a Registered Trademark of Merck & Co, Inc Used under license.... |
| |
| 8. | Asthma - Parents |
| | PrSINGULAIR ® (montelukast sodium) is a Registered Trademark of Merck & Co, Inc Used under license.... |
| |
